This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Gen Psychiatry. 1984;41(5):527-528.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We read with interest the much-needed recent report by Razani et al¹ concerning the efficacy and safety of combined amitriptyline hydrochloride and tranylcypromine sulfate antidepressant treatment. This letter is to reaffirm that safe practice and to report the use of another safe drug combination, phenelzine sulfate and trazodone hydrochloride, in five cases.

Report of Cases.

—CASE 1.—A 26-yearold divorced woman had "mood swings" and neurovegetative symptoms of depression. The patient did not experience significant symptom amelioration with a course of 175 mg/day of imipramine hydrochloride or of 75 mg/day of nortriptyline hydrochloride with 4 mg of perphenazine three times a day, but did experience urinary retention. Because of the clinical course, as well as a history of mixed drug abuse in adolescence, a diagnosis of "hysteroid dysphoria"² was considered and 15 mg of phenelzine sulfate three times a day was prescribed. The patient experienced relief . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?